Fintel reports that on February 3, 2025, Redburn Atlantic upgraded their outlook for DexCom (NasdaqGS:DXCM) from Neutral to ...

Let's sort the S&P 500 healthcare sector again to show the 10 stocks with the highest percentages of "buy" or equivalent ratings. Only five companies are on both this list and the above growth list: ...

The bull market of the past year or more has reinvigorated investors' interest across a range of industries, and the ...

In the Spring 2024 semester, Glucoguard was invited to participate in the MADO program through our ongoing relationship with ...

Geneos Wealth Management Inc. lessened its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 2.6% in the ...

Exchange Traded Concepts LLC decreased its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 12.4% in the ...

DexCom Inc. closed 38.30% below its 52-week high of $142.00, which the company achieved on March 26th.

On Monday, DexCom Inc (DXCM) stock saw a decline, ending the day at $87.53 which represents a decrease of $-1.22 or -1.37% from the prior close of $88.75. The stock opened at $88.58 and touched a low ...

DexCom (NASDAQ:DXCM) shares received an optimistic update from Redburn-Atlantic, with analyst Issie Kirby (NYSE:KEX) upgrading the stock from Neutral to Buy and increasing the price target to $115 ...

The S&P 500 index trades at a forward price/earnings ratio of 21.9. The U.S. large-cap benchmark stock index is weighted by market capitalization. The index's current forward P/E valuation is 18% ...

In a report released today, Larry Biegelsen from Wells Fargo maintained a Buy rating on Stryker (SYK – Research Report), with a price target of ...

As eight-year-old Elizabeth Struhs lay dying from a diabetes-induced ketoacidosis, the medicine that could have saved her ...